Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATNon-Current ReceivablesOther Gross PP&E AdjustmentsShort-Term Debt issuances
Ratios

Dr Reddys Laboratories (RDY) Long-Term Debt Repayments (2016)

Historic Long-Term Debt Repayments for Dr Reddys Laboratories (RDY) over the last 3 years, with Q4 2016 value amounting to -$76.7 million.

  • Dr Reddys Laboratories' Long-Term Debt Repayments fell 3170064.41% to -$76.7 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$77.3 million, marking a year-over-year increase of 6295.93%. This contributed to the annual value of -$45.9 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2016, Dr Reddys Laboratories' Long-Term Debt Repayments is -$76.7 million, which was down 3170064.41% from -$403387.8 recorded in Q3 2016.
  • Dr Reddys Laboratories' 5-year Long-Term Debt Repayments high stood at $242865.1 for Q4 2015, and its period low was -$140.1 million during Q3 2015.
  • Over the past 3 years, Dr Reddys Laboratories' median Long-Term Debt Repayments value was -$693958.5 (recorded in 2014), while the average stood at -$31.9 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Long-Term Debt Repayments skyrocketed by 10085.79% in 2015, and later crashed by 3170064.41% in 2016.
  • Dr Reddys Laboratories' Long-Term Debt Repayments (Quarter) stood at -$28.3 million in 2014, then soared by 100.86% to $242865.1 in 2015, then crashed by 31700.64% to -$76.7 million in 2016.
  • Its Long-Term Debt Repayments stands at -$76.7 million for Q4 2016, versus -$403387.8 for Q3 2016 and -$418840.0 for Q2 2016.